Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

AUTOR(ES)

Reig, M

RESUMO

The activities of erythromycin and clindamycin against 350 Peptostreptococcus strains were studied during a 5-year period (1986 to 1991). In 5.1% of the Peptostreptococcus strains, which presented dissociated resistance (clindamycin MIC, less than or equal to 1 microgram/ml; erythromycin MIC, greater than 8 micrograms/ml), evidence of inducible macrolide-lincosamide resistance was shown. A total of 17.7% of the strains presented a constitutive phenotype; the clindamycin and erythromycin MICs for these strains were greater than 8 micrograms/ml.

Documentos Relacionados

• Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species.
• Novel mechanisms of resistance to lincosamides in Staphylococcus and Arthrobacter spp.
• A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis.
• Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil
• Distribution of Genes Encoding Resistance to Macrolides, Lincosamides, and Streptogramins among Staphylococci